Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Thank you for standing by. And welcome to Invivyd’s First Quarter ...

Retail buzz around Invivyd Inc. spiked on Monday after it revealed its launch of a discovery program to create a ...

PEMGARDA™ (pemivibart) net product revenue of $11.3 million reported for Q1 2025, influenced by planned transition (Jan/Feb) from a contracted to an internalized sales forcePEMGARDA revenue ...

Katie Falzone; Senior Vice President, Finance; Invivyd Inc. Marc Elia; Independent Chairman of the Board; Invivyd Inc. Tim Lee; Chief Commercial Officer; Invivyd Inc ...

PEMGARDA™ (pemivibart) uptake continues to grow among healthcare providers caring for immunocompromised patients, supported by Invivyd’s in-house sales force and expanded field presence across ...

Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ETCompany ParticipantsKatie Falzone - Senior Vice President, ...

May 15, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced financial results for the quarter ended March 31, 2025, and provided recent business highlights. “To drive long-term ...

PEMGARDA™ (pemivibart) net product revenue of $11.3 million reported for Q1 2025, influenced by planned transition (Jan/Feb) from a contracted to an internalized sales force PEMGARDA revenue ...